Patents by Inventor Richard E. Paylor

Richard E. Paylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzamides for neurodegenerative disorder treatment
    Patent number: 6140369
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease or Alzheimer's which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: October 31, 2000
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William David Flitter, William A. Garland, Allan L. Wilcox, Richard E. Paylor
  • Benzamides for neurodegenerative disorder treatment
    Patent number: 5955506
    Abstract: A group of benzamide compounds are disclosed. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The pharmaceutical compositions can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: September 21, 1999
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William David Flitter, William A. Garland, Allan L. Wilcox, Richard E. Paylor
  • Benzamide-containing pharmaceutical compositions
    Patent number: 5472983
    Abstract: A group of benzamide compounds are disclosed that are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from neurodegenerative conditions associated with dopamine depletion.
    Type: Grant
    Filed: April 14, 1994
    Date of Patent: December 5, 1995
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, Kirk R. Maples, Richard E. Paylor, Helming Tan, Allan L. Wilcox